Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small-Cell Lung Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00783471
What this trial is testing

Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Hellenic Cooperative Oncology Group 51
Testing effectiveness (Phase 2)Study completedNCT04647344
What this trial is testing

AK104 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer Non-Small Cell Stage IIIB/IIIC/IV
Akeso 46
Not applicableApproved For MarketingNCT04829422
What this trial is testing

Early Access Program of Lazertinib in Republic of Korea

Who this might be right for
Lung Cancer
Yuhan Corporation
Not applicableUnknownNCT01877902
What this trial is testing

Study Of Use Of Pemetrexed In Patients With Non-Small Lung Cancer Metastatic In Andalusian Public Health System

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Fundación Pública Andaluza Progreso y Salud 190
Testing effectiveness (Phase 2)UnknownNCT01210053
What this trial is testing

Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Third Military Medical University 30
Testing effectiveness (Phase 2)UnknownNCT05900219
What this trial is testing

Efficacy and Safety of HL-085 Combined With Vemurafenib in BRAF V600E Patients With Non-small Cell Lung Cancer: a Phase II Clinical Study

Who this might be right for
Non-small-cell Lung Cancer
Shanghai Kechow Pharma, Inc. 75
Large-scale testing (Phase 3)Looking for participantsNCT05085028
What this trial is testing

A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer, Nonsmall Cell
Imperial College London 1,750
Testing effectiveness (Phase 2)Study completedNCT00379665
What this trial is testing

Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Southwestern Regional Medical Center 25
Not applicableActive Not RecruitingNCT07718139
What this trial is testing

Demographics, Clinical Characteristics and Outcomes in Resected Non-Small Cell Lung Cancer Patients Receiving Immunotherapy in Europe and Canada

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 300
Early research (Phase 1)Looking for participantsNCT05948865
What this trial is testing

CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
CancerCancer, Lung
Conjupro Biotherapeutics, Inc. 132
Early research (Phase 1)Not Yet RecruitingNCT07558200
What this trial is testing

Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorsNon-Small Cell Lung CancerHepatocellular Carcinoma
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 138
Testing effectiveness (Phase 2)Study completedNCT00039507
What this trial is testing

Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03812809
What this trial is testing

A Phase IIb Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients With T790M Mutation Positive

Who this might be right for
NSCLC
Beta Pharma Shanghai 226
Early research (Phase 1)UnknownNCT05942508
What this trial is testing

A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and Chemotherapy

Who this might be right for
Limited Stage Small Cell Lung CancerNot Progressed After First-line Chemoradiotherapy
Jinming Yu 20
Not applicableStudy completedNCT01790217
What this trial is testing

An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer (GERTAC)

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 52
Not applicableEnded earlyNCT00912366
What this trial is testing

Assessment of Video Assisted Thoracoscopic Surgery (VATS) Versus Open Surgery for Patients Undergoing Lobectomy

Who this might be right for
Non Small Cell Lung Cancer
Medtronic - MITG 39
Not applicableEnded earlyNCT02688166
What this trial is testing

Cardiac MRI Biomarker Testing (GCC 1618)

Who this might be right for
Breast CancerLung Cancer (Non-Small Cell)Thoracic Cancer+2 more
University of Maryland, Baltimore 6
Testing effectiveness (Phase 2)Study completedNCT03158129
What this trial is testing

Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer

Who this might be right for
Stage I Lung Non-Small Cell Cancer AJCC v7Stage IA Lung Non-Small Cell Carcinoma AJCC v7Stage IB Lung Non-Small Cell Carcinoma AJCC v7+4 more
M.D. Anderson Cancer Center 101
Not applicableUnknownNCT02851329
What this trial is testing

Therapeutic Resistance Prediction of Tyrosine Kinase Inhibitors

Who this might be right for
Non-small Cell Lung Cancer
Chinese Academy of Sciences 500
Large-scale testing (Phase 3)UnknownNCT02859077
What this trial is testing

EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism

Who this might be right for
Non-Small-Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 100
Next Page